Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Depreciation ExpenseEBIATLeasesNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - OtherShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

AC Immune (ACIU) Shares Outstanding (2017 - 2025)

AC Immune has reported Shares Outstanding over the past 9 years, most recently at $127.3 million for Q4 2025.

  • Quarterly Shares Outstanding rose 11.06% to $127.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $127.3 million through Dec 2025, up 11.06% year-over-year, with the annual reading at $127.3 million for FY2025, 11.06% up from the prior year.
  • Shares Outstanding was $127.3 million for Q4 2025 at AC Immune, up from $114.6 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $127.3 million in Q4 2025 and troughed at $86.8 million in Q4 2022.
  • The 5-year median for Shares Outstanding is $111.8 million (2023), against an average of $106.2 million.
  • Year-over-year, Shares Outstanding dropped 4.12% in 2022 and then grew 28.84% in 2023.
  • A 5-year view of Shares Outstanding shows it stood at $90.5 million in 2021, then decreased by 4.12% to $86.8 million in 2022, then grew by 28.84% to $111.8 million in 2023, then increased by 2.49% to $114.6 million in 2024, then increased by 11.06% to $127.3 million in 2025.
  • Per Business Quant, the three most recent readings for ACIU's Shares Outstanding are $127.3 million (Q4 2025), $114.6 million (Q4 2024), and $111.8 million (Q4 2023).